Published May 4, 2007
| Version v1
Journal article
The CD95 receptor: apoptosis revisited.
- Others:
- Ben May Department for Cancer Research ; University of Chicago
- Department of Medicine, Univ. Vermont ; University of Vermont [Burlington]
- Department of Physiology [Montréal] ; McGill University = Université McGill [Montréal, Canada]
- University of California [San Diego] (UC San Diego) ; University of California (UC)
- Institut de signalisation, biologie du développement et cancer (ISBDC) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA)
- Institute of Bioenergetics, Univ. Colorado ; University of Colorado [Boulder]
- University of California [Riverside] (UC Riverside) ; University of California (UC)
- Division of Rheumatology ; Northwestern University
- Department of Biochemistry [Lausanne] ; Université de Lausanne = University of Lausanne (UNIL)
- Department of Molecular Internal Medicine, Univ. Wuerzburg ; University of Würzburg
- Department of Biological Chemistry ; Weizmann Institute of Science [Rehovot, Israël]
- Laboratory of Experimental Immunology ; National Cancer Institute [Bethesda] (NCI-NIH) ; National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH)
- Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus
- Bainbridge Biopharma Consulting ; Bainbridge Biopharma
Description
CD95 is the quintessential death receptor and, when it is bound by ligand, cells undergo apoptosis. Recent evidence suggests, however, that CD95 mediates not only apoptosis but also diverse nonapoptotic functions depending on the tissue and the conditions.
Additional details
- URL
- https://hal.archives-ouvertes.fr/hal-00318978
- URN
- urn:oai:HAL:hal-00318978v1
- Origin repository
- UNICA